|
⚲
|
| Keyboard |
| Paulsen Gisela
✚
|
|
|---|---|
| CIK # | 0001807104 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001807104] | |
| 4 | [0001807104] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Oncocyte Corp | |
| Paulsen Gisela | |
| Exact Sciences Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2022-12-16 | Disposed to issuer | 171,875 | $0.00 | |
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2022-12-16 | Disposed to issuer | 125,000 | $0.00 | |
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2022-12-16 | Disposed to issuer | 70,313 | $0.00 | |
|
Oncocyte Corp OCX
Common Stock, no par value
|
2022-12-01 | Disposed to issuer | 175,000 | $0.00 | |
|
Oncocyte Corp OCX
Common Stock, no par value
|
2022-08-15 | Grant | 175,000 | $0.00 | |
|
Oncocyte Corp OCX
Common Stock, no par value
|
2022-08-15 | Grant | 350,000 | $0.00 | |
|
Oncocyte Corp OCX
Common Stock, no par value
|
2022-03-17 | Buy | 16,500 | $1.20 | 19,800 |
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2022-03-15 | Grant | 125,000 | $0.00 | |
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2022-03-15 | Grant | 125,000 | $0.00 | |
|
Exact Sciences Corp EXAS
Restricted Stock Units · derivative
|
2020-04-20 | Grant | 66,267 | $0.00 |